XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues      
Total Revenues $ 5,578.9 $ 5,019.4 $ 4,689.7
Expenses      
Compensation and benefits 828.6 753.1 837.0
Technology 218.7 188.6 192.6
Professional fees and outside services 144.4 137.4 151.7
Amortization of purchased intangibles 226.6 227.7 237.6
Depreciation and amortization 126.0 134.9 147.8
Licensing and other fee agreements 322.8 320.0 236.9
Other 276.1 241.8 240.9
Total Expenses 2,143.2 2,003.5 2,044.5
Operating Income 3,435.7 3,015.9 2,645.2
Non-Operating Income (Expense)      
Investment income 5,275.3 2,198.4 306.9
Interest and other borrowing costs (159.4) (162.7) (166.9)
Equity in net earnings (losses) of unconsolidated subsidiaries 296.9 301.1 245.8
Other income (expense) (4,694.9) (1,862.4) 342.6
Total Non-Operating 717.9 474.4 728.4
Income before Income Taxes 4,153.6 3,490.3 3,373.6
Income tax provision 927.4 799.3 736.7
Net income 3,226.2 2,691.0 2,636.9
Net Income (Loss) Attributable to Noncontrolling Interest 0.0 0.0 0.5
Net income attributable to CME Group 3,226.2 2,691.0 2,636.4
Net Income Attributable to Common Shareholders of CME Group $ 3,185.6 $ 2,657.2 $ 2,617.1
Earnings per Common Share Attributable to CME Group:      
Basic $ 8.87 $ 7.41 $ 7.30
Diluted $ 8.86 $ 7.40 $ 7.29
Weighted Average Number of Common Shares:      
Basic 359,023 358,713 358,340
Diluted 359,500 359,181 358,929
Clearing and Transaction Fees [Member]      
Revenues      
Total Revenues $ 4,588.5 $ 4,142.7 $ 3,765.1
MarketData [Member]      
Revenues      
Total Revenues 663.7 610.9 576.9
OtherRevenue [Member]      
Revenues      
Total Revenues $ 326.7 $ 265.8 $ 347.7